Tukysa Unia Europejska - duński - EMA (European Medicines Agency)

tukysa

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiske midler - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Copiktra Unia Europejska - duński - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Ketoconazole HRA Unia Europejska - duński - EMA (European Medicines Agency)

ketoconazole hra

hra pharma rare diseases - ketoconazol - cushing syndrome - antimykotika til systemisk brug - ketoconazol hra er indiceret til behandling af endogent cushings syndrom hos voksne og unge over 12 år.

Curosurf 80 mg/ml endotracheopulmonal instillationsvæske, suspension Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

curosurf 80 mg/ml endotracheopulmonal instillationsvæske, suspension

chiesi farmaceutici s.p.a. - phospholipidfraktion fra griselunge - endotracheopulmonal instillationsvæske, suspension - 80 mg/ml